Synthetic biology promises to revolutionize manufacturing, growing materials in fermentation tanks instead of relying on traditional industrial or agricultural sources. But can it scale? Zero100 Chief Content Officer Matt Davis sits down with Mathias Cousin, Managing Director at Monitor Deloitte and a SynBio veteran, to find out. Mathias reveals why manufacturing economics, not science, determines who survives, how AI is compressing design cycles from years to months, and why the biggest breakthroughs may come from replacing cows, not crude oil. With real-world examples, he shows what supply chain leaders need to understand as biological manufacturing moves from the lab to industrial reality.